Leigh Zawel - Oct 7, 2021 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Scientific Officer, Small Molecules
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Oct 7, 2021
Transactions value $
-$26,975
Form type
4
Date filed
10/12/2021, 04:30 PM
Previous filing
Sep 21, 2021
Next filing
Oct 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$27K -1.08K -1.86% $25.00 56.9K Oct 7, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 26, 2021.

Remarks:

Chief Scientific Officer, Small Molecules